The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 1. Definition, Methodology and First-line Management
Woo‐Jung Song, Mira Choi, Dong Hun Lee, Jae‐Woo Kwon, Gun-Woo Kim, Myung Hwa Kim, Mi‐Ae Kim, Min‐Hye Kim, Byung‐Keun Kim, Sujeong Kim, Joung Soo Kim, Jung Eun Kim, Ju‐Young Kim, Joo‐Hee Kim, Hyun Jung Kim, Hye One Kim, Hyo‐Bin Kim, Joo Young Roh, Kyung Hee Park, Kui Young Park, Han‐Ki Park, Hyunsun Park, Jung Min Bae, Ji Yeon Byun, Dae Jin Song, Young Min Ahn, Seung Eun Lee, Young Bok Lee, Joong Sun Lee, Ji Hyun Lee, Kyung-Hwan Lim, Young‐Min Ye, Yoon‐Seok Chang, You Hoon Jeon, Jiehyun Jeon, Mihn‐Sook Jue, Sun Hee Choi, Jeong‐Hee Choi, Gyu Young Hur, Young Min Park, Dae Hyun Lim, Sang Woong Youn
Abstract
Chronic spontaneous urticaria (CSU) is defined as the occurrence of spontaneous wheals, angioedema, or both for >6 weeks in the absence of specific causes. It is a common condition associated with substantial disease burden both for affected individuals and societies in many countries, including Korea. CSU frequently persists for several years and requires high-intensity treatment; therefore, patients experience deteriorations in quality of life and medication-associated complications. During the last decade, there have been major advances in the pharmacological treatment of CSU and there is an outstanding need for evidence-based guidelines that reflect clinical practice in Korea. The guidelines reported here represent a joint initiative of the Korean Academy of Asthma, Allergy and Clinical Immunology and the Korean Dermatological Association, and aim to provide evidence-based guidance for the management of CSU in Korean adults and children. In Part 1, disease definition, guideline scope and development methodology as well as evidence-based recommendations on the use of antihistamines and corticosteroids are summarized.